Greenwood Village, Colorado-based Revelation Pharma has announced its acquisition of Washington-based Cascade Specialty Pharmacy. The acquisition of Cascade Specialty Pharmacy brings ear, nose and throat (ENT) and animal health compounding to Revelation Pharma’s growing portfolio.
Cascade Specialty Pharmacy is located in Poulsbo, Washington and is licensed for shipping to 13 states. Known for its sinus preparations, Cascade has been actively serving patients and providers in the Poulsbo community since 1977. The company offers medicine for both humans and animals.
Revelation Pharma is a national network of 503A and 503B compounding pharmacies providing personalized pharmaceutical preparations, products and services through patient care and solutions for customers.
Cascade will continue to operate in its current location in Poulsbo, with existing customers now having new options for fulfillment that will help extend offerings and expedite delivery. The pharmacy’s full therapeutic lines of focus will be maintained, focusing on Cascade’s ENT offerings.
Cascade’s former owner, Brandon Knott, will remain actively involved with Cascade, collaborating with the Revelation Pharma team as an ENT allergy product specialist to expand and enhance the services provided by the entire network of pharmacies. Financial terms of the deal were not disclosed.
According to data captured in the LevinPro HC database, this acquisition represents the fourth Specialty Pharmacy transaction of 2025. There were 25 Specialty Pharmacy transactions announced during 2024, 29 announced during 2023 and 35 announced during 2022.
This also marks Revelation Pharma’s second Specialty Pharmacy acquisition of 2025. Earlier in the month, the company acquired Phoenix, Arizona-based AleraCare Pharmacy for an undisclosed price. In July 2024, Revelation Pharma acquired Taylors Pharmacy in Winter Park, Florida and Key Compounding Pharmacy in Federal Way, Washington.
